The report, released at Global Pharmaceutical Quality Summit in Mumbai, draws comparison of incidences of ‘official action indicated' after USFDA inspections a decade apart.
Five-member panel suggests doctors can't be given brand reminders exceeding Rs 1,000 each, Uniform Code of Pharmaceutical Marketing Practices to remain voluntary, but strengthened.
The appearance in US maps of Hodgson’s Line, joining NJ 9842 with the Karakoram Pass, sowed the seeds of Pakistan’s Siachen claim. Its correction by US agencies changed nothing.
Low salaries, little growth in corporate jobs and F&O losses, the assumptions that once built middle class security are no longer applicable to the emerging Indian economy.
COMMENTS